Page 16 - Avoid Food and Drug Interactions

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved. Evidence of PN Use to Treat Malnutrition

Pre-operative PN

• No difference

o Baseline Clinical and laboratory characteristics
o Postoperative complications
o Outcome parameters

- Infectious complications
- Morbidity
- Mortality
- Hospital stay

• Evidence of comparable PN outcomes with EN in MN cancer patients

Klek S et al Clin Nutr 30:708, 2011

27

Evidence of PN Use to Improve Lean Body Mass

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved. Long Term PN in Pancreatic Cancer

• N = 32, 18 (8-35) weeks
• Advanced pancreatic cancer and cachexia

o Excessive weight loss despite additional enteral nutrition support

• BIA method

o Phase angle
o ECM/BCM index
o BMI

ECM/BCM – extracellular mass/body cell mass
Pelzer U et al. BMC Cancer !0:86, 2010

28

16